Injective has rallied more than 8% on October 16, reaching $9.35 as increased trading activity and renewed interest in the network’s institutional developments have supported its recovery. According to TradingView data from Binance, INJ (INJ) was trading near $9.25 at…MarketsRead More

You might also be interested in reading Zoetis raises 2025 organic operational revenue growth guidance to up to 8% while advancing key franchises.